Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Trinity Biotech (TRIB) Construction in Progress (2016 - 2018)

Trinity Biotech's Construction in Progress history spans 3 years, with the latest figure at $204000.0 for Q4 2018.

  • On a quarterly basis, Construction in Progress fell 63.64% to $204000.0 in Q4 2018 year-over-year; TTM through Dec 2018 was $204000.0, a 63.64% decrease, with the full-year FY2018 number at $204000.0, down 63.64% from a year prior.
  • Construction in Progress hit $204000.0 in Q4 2018 for Trinity Biotech, down from $561000.0 in the prior quarter.
  • Over the last five years, Construction in Progress for TRIB hit a ceiling of $778000.0 in Q4 2016 and a floor of $204000.0 in Q4 2018.
  • Historically, Construction in Progress has averaged $514333.3 across 3 years, with a median of $561000.0 in 2017.
  • Biggest five-year swings in Construction in Progress: fell 27.89% in 2017 and later crashed 63.64% in 2018.
  • Tracing TRIB's Construction in Progress over 3 years: stood at $778000.0 in 2016, then decreased by 27.89% to $561000.0 in 2017, then crashed by 63.64% to $204000.0 in 2018.
  • Business Quant data shows Construction in Progress for TRIB at $204000.0 in Q4 2018, $561000.0 in Q4 2017, and $778000.0 in Q4 2016.